Gjensidige Forsikring ASA (0OJC)
London Exchange · UK · prices in NOK · close of 20 Oct 2026
Key indicators
| Last close | NOK 264.90 |
|---|---|
| 52-week range | 241.80 – 297.59 |
| Return, 1 month / 3 months | −4.1% / −5.3% |
| Return, 1 year / 3 years | −3.6% / +75.7% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 18.5% |
| Worst drawdown (1 year) | -17.8% |
| Average daily value traded | 10.93M NOK |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gjensidige Forsikring is an insurance company based in Norway. It provides property and casualty insurance to private individuals and to businesses, covering homes, vehicles and other everyday risks. The company also offers pension and savings products and runs a banking operation. Its customers are mainly in Norway and neighbouring Nordic markets, where it serves households and commercial clients through its own distribution channels and partners.
On this site Gjensidige Forsikring ASA appears as a stock on the London Exchange (UK), code 0OJC, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gjensidige Forsikring ASA (0OJC) trades on the London Exchange in UK. It last closed at NOK 264.90 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,034 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.6% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.6% | ||
| From 52-week high | -11.0% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | 0.8% | ||
| 12-month return, skipping the last month | 0.5% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.8% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.93M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | −4.1% |
| 3 months | −5.3% |
| 6 months | +0.8% |
| 1 year | −3.6% |
| 3 years | +75.7% |
| 5 years | +52.8% |
Signals
| 50-day / 200-day average | 271.05 / 266.50 |
|---|---|
| Golden / death cross (60 days) | Golden, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | NOK 4.5000 |
| 21 Mar 2025 | NOK 1.0000 |
| 21 Mar 2024 | NOK 8.7500 |
| 24 Mar 2023 | NOK 8.2500 |
| 25 Mar 2022 | NOK 7.7000 |
| 8 Nov 2021 | NOK 4.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.